共 50 条
- [1] Real-World Outcomes of Ruxolitinib Treatment for Polycythemia Vera [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (10): : 697 - +
- [3] Real-World Dosing Patterns of Ruxolitinib in Patients with Polycythemia Vera Who are Resistant to or Intolerant of Hydroxyurea [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S326 - S327
- [5] Real-World Dosing Patterns of Ruxolitinib in Patients With Polycythemia Vera Who Are Resistant to or Intolerant of Hydroxyurea [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (11): : E915 - E921
- [9] THERAPY OF THE POLYCYTHEMIA VERA WITH RUXOLITINIB [J]. GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2017, 62 (04): : 229 - 232
- [10] Ruxolitinib for treatment of polycythemia vera [J]. EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (09): : 1085 - 1096